|
| |
Subarachnoid haemorrhage
Charles Gomersall & Ross Calcroft
Epidemiology
- overall M=F. In patients <40 yrs M>F, >50 yrs M<F
- peak incidence 55-60 yrs
Aetiology
- intracranial aneurysm (18-76%)
- AVM (6%)
- trauma
- neoplasm
- coagulopathy
- collagen vascular disease
- sickle cell anaemia
- cerebral infarction
- drug abuse
Pathogenesis
- vast majority of intracranial aneurysms are saccular (berry) aneurysms
- less common types are atherosclerotic, mycotic and traumatic
- saccular aneurysms occur at bifurcation of arteries forming circle of Willis,
and at bifurcation of those arteries that arise from circle of Willis. 90-95%
occur in anterior part of circle of Willis. 5-10% in vertebrobasilar system.
Originally thought to be congenital and due to a defect in tunica media. Now
thought that they are acquired. Due to degeneration of internal elastic membrane
at apex of bifurcation due to haemodynamic stress, producing initial sac.
Enlargement due to hypertension and turbulent flow in sac which produces further
degeneration of aneurysm wall. Picture
- risk of rupture increases with increasing size. Usually occurs when aneurysm
reaches 5-10 mm diameter.
- rupture commonly occurs in association with activities that increase BP
- of the various environmental factors that may confer a
predisposition to SAH, cigarette smoking is the only factor that has
consistently been identified in all the populations studied. Hypertension is the
most frequently studied risk factor for SAH; several studies have shown an
increased risk with hypertension. ? role of hormonal factors-different incidence
between men and women at different ages. Moderate to high alcohol consumption:
is an independent risk factor for SAH. Data for hypercholesterolaemia are
inconsistent
- considerable evidence supports the role of
genetic factors in the pathogenesis of aneurysms.
Clinical features
- premonitory features in many patients. May be headache, orbital pain,
diplopia, ptosis, visual loss, fits, motor or sensory deficit, dysphasia, bruit
or dizziness. Due to sentinel haemorrhage preceding major bleed
- headache (85-95%). Sudden and intense
- followed by pain radiating into the occipital or cervical region
- nuchal rigidity and other signs of meningism
- photophobia, nausea, vomiting, lethargy or altered mentation
- variable conscious level. Depends on size of haematoma, development of
hydrocephalus, ICP, vasospasm and cerebral blood flow
- may be motor or sensory deficits, hyper-reflexia, visual field deficits,
abnormal BS reflexes, abnormal motor posturing
- mild pyrexia
- hypertension
- intraocular haemorrhages. Subhyaloid or pre-retinal haemorrhages in particular
are associated with SAH. Subhyaloid haemorrhages appear as bright red, sharply
demarcated regions adjacent to optic disc
- III nerve palsy associated with PCA aneurysms, less frequently may be seen in
association with other aneurysms
Investigations
CT
(image)
- will demonstrate subarachnoid blood in 85% of patients scanned within 48 h
of bleed.
- distribution of blood may give an indication of location of aneurysm eg blood
within supratentorial ventricular system often due to ruptured ACA aneurysm,
focal blood in 4th ventricle associated with vertebral artery aneurysm in
vicinity of PICA
LP
- may confirm diagnosis if CT is negative but procedure not without risk in
patients with SAH
- significant neurological deterioration following LP in 10-15%.
- xanthochromia develops only after RBCs lyse. Detectable after 4 h, maximal at
1 week, usually undetectable at 3 weeks
- if CSF is bloody due to SAH blood usually will not clot if left to stand
4 vessel angiography
- as soon as patient is fit enough.
- complications include transient hemiparesis, permanent neurological deficits,
death, worsening of ischaemic deficit, aneurysmal
re-bleeding.
- overall complication rate should be <1% with an experienced
neuroradiologist
- 3D angiography useful in assessing neck of aneurysm and determining best
angle of approach when using endovascular coiling
Image
CT angiography
- some evidence to suggest that this has a similar sensitivity to
conventional angiography
- advantages are short time for data acquisition and ability to reconstruct
multiple views from the raw data
- disadvantages: exposure to IV contrast
Image
MRI
- not useful in the acute diagnosis of SAH but helpful in identifying most
probable source of haemorrhage when multiple aneurysms found on angiography and
in assessment of giant intracerebral aneurysms
- MR angiography sensitivity only 90% when compared to DSA. Also, has limited
resolution in the setting of vasospasm
ICP monitoring
- useful in comatose patients and those with cerebral oedema and
hydrocephalus
Transcranial Doppler
- increases in mean arterial velocity may be associated with vasospasm but
TCD is not a reliable method of diagnosing vasospasm
Somatosensory evoked potentials
- may be indicative of clinical grades and neurological deficits,
particularly intra-operatively
Grading
Hunt & Hess '74
- Grade 0: Unruptured aneurysm without symptoms
- Grade 1: Asymptomatic or minimal headache and slight nuchal rigidity
- Grade 1a: No acute meningeal or brain reaction, but with fixed neurological
deficit
- Grade 2: Moderate-to-severe headache, nuchal rigidity, no neurological
deficit other than cranial nerve palsy
- Grade 3 Drowsy, confused, or mild focal deficit
- Grade 4 Stupor, moderate-to-severe hemiparesis, possible early decerebrate
rigidity and vegetative disturbances
- Grade 5 Deep coma, decerebrate rigidity, moribund appearance
Presence of serious systemic disease or vasospasm puts patient into next
worse grade
NB Important to specify name and date of classification system to allow
comparability of patients. Original Hunt & Hess classification published in
1968.
World Federation of Neurological Surgeons
|
Grade |
GCS |
Motor deficit |
|
I |
15 |
Absent |
|
II |
13-14 |
Absent |
|
III |
13-14 |
Present |
|
IV |
7-12 |
Absent/present |
|
V |
3-6 |
Absent/present |
Fischer scale
| Grade |
Description |
| 1 |
No clot seen on CT scan |
| 2 |
Diffuse thin layer of SA clot (<1mm thickness) |
| 3 |
Localised clot or thicker layer of SA clot (>1mm thickness) |
| 4 |
Intracerebral
or intraventricular clot with diffuse or no SA clot. |
Management
- control blood pressure except in patients with cerebral vasospasm. Use
sedation, analgesics and antihypertensives. b
blockers, methyldopa and hydralazine have been used. Maintain circulating volume
and avoid hypotension
- calcium antagonists
- Nimodipine drug of
choice
- Nicardipine as effective but
more likely to cause hypotension
- Do not alter incidence of vasospasm but do
improve mortality. It appears that the beneficial activity of this drug is in
the decrease of neuronal calcium, which is elevated following injury.
- Neurologic outcome and mortality rates of SAH victims prophylactically
treated with 4mg/kg/day nimodipine are improved 25-50% over controls. (Has
been shown to decrease the incidence of overall cerebral infarction after
SAH by 34% and the incidence of poor outcome by 45%). Fewer infarcts are
noted, although the incidence of vasospasm is not altered.
- Side effects of nimodipine are mild and include mild hypotension.
- Current recommendations are to administer 60 mg of nimodipine orally/IV
every 4 hours for a 21 day course beginning at the onset of the SAH.
- free radical scavengers: free iron can catalyse
free radical reactions, including lipid peroxidation.
- Nizofone has shown some promising results. Also trilazad which inhibits;
lipid peroxidation and protects cell membranes by scavenging free radicals,
similar to Vit E.
- serial CT to detect hydrocephalus and rebleeding
- use of antifibrinolytics (eg epsilon aminocaproic acid) to prevent clot lysis
and rebleeding controversial. Associated with increase in ischaemic neurological
deficits, increased incidence of hydrocephalus, and diarrhoea. Probably have
little role in patients who are to undergo early surgery and do not alter
mortality
- maintenance of fluid and electrolyte balance
Surgical/radiological intervention
- Early surgery for aneurysmal SAH associated with lower incidence of
rebleeding but increased incidence of vasospasm and mortality is the same.
Possible exception are those patients who are alert and have a low grade on
admission who have most favourable results with early surgery
Endovascular therapy
- most amenable aneurysms are those with narrow necks
- early experience is that procedural risks are fairly low (periprocedural
haemorrhage rate is 2%, with the permanent morbidity and mortality rates at
0% and 0.5% respectively) but long term effectiveness is not yet proven
- First line therapy for:
- ruptured posterior circulation aneurysm
- ruptured small (<10 mm) anterior circulation aneurysm in good grade patients
(World Federation of Neurological Surgeons grade I-III)
- aneurysm causing nerve compression
- unruptured aneurysm where risk:benefit ratio favours any treatment at
all
- International Subarachnoid Aneurysm Trial (SAT):
- prospective randomized comparative trial
- 2143 patients with ruptured aneurysm that in opinion of clinician that was equally amenable to
surgery or coiling
- mainly small, anterior circulation aneurysms
- mainly good grade SAH
- ~24% of coiled patients dead or dependent at 1 year compared to ~31% of patients
undergoing surgery. Improvement predominantly due to decreased incidence
of dependency (mortality at 1 year was ~8% and ~10%)
Post-operative complications
- brain swelling
- bleeding at operative site
- complications of SAH
- vasospasm
- EDH, SDH, ICH, hydrocephalus
- metabolic abnormalities.
Complications
Re-bleeding
- Incidence depends on site of aneurysm, presence of clot, degree of
vasospasm, age and sex.
- 16-25% incidence in first 2 weeks with associated mortality of 40%.
- Frequency highest in first 48 h.
- Incidence only 4% in first 6 months for the 20% of patients in whom no
source of SAH discovered. Re-bleeding less common after SAH due to AVM than
following aneurysmal SAH
Vasospasm
Details
Hydrocephalus.
- Communicating hydrocephalus may develop in up to 1/3 of patients, especially
patients with ruptured anterior communicating artery aneurysms.
- Due to fibrosis in subarachnoid space.
- May cause a decreased level of consciousness a few days/weeks after SAH.
- Occasionally disturbance of CSF flow may not be present until some years
after SAH and clinical picture is then one of "normal" pressure
hydrocephalus
Cerebral oedema
Image
Electrolyte disturbance
- DI
- SIADH
- cerebral salt wasting
Others
- fits
- ECG changes: T inversion, ST changes, U waves, QT prolongation
- arrhythmias
- sympathetic hyperactivity
- reduction in total blood volume and in red cell mass
Seizures
- seizures or seizure-like episodes are reported in
approximately 13%-26%
- routine use of prophylactic anticonvulsants is not recommended, unless in
the presence of risk factors such as MCA aneurysm, intraparenchymal haemorrhage,
infarcts and history of hypertension or seizures.
Prognosis
|
Grade (Hunt & Hess) |
Mortality (%) |
|
I |
1 |
|
II |
5 |
|
III |
19 |
|
IV |
42 |
|
V |
77 |
|
Total |
18 |
There is limited evidence that patients with poor grade (Hunt & Hess IV
or V) may do moderately well with aggressive management with 57% of grade IV and
53% of grade V being independent in daily activities at 3 months
Further reading
Commichau C, Mayer SA. Critical care of subarachnoid and intracerebral
hemorrhage. Current Opinion in Critical Care, 1998; 4:94-100
International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group.
International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping
versus endovascular coiling in 2143 patients with ruptured intracranial
aneurysms: a randomised trial
Oropello JM, Weiner L, Benjamin E. Hypertensive, hypervolaemic,
hemodilutional therapy for aneurysmal subarachnoid haemorrhage. Is it
efficacious ? No. Critical Care Clinics, 1996; 12: 709
Johnstone SC Stroke 2000 31:111-117
Ullman JS, Bederson JB. Hypertensive, hypervolaemic, hemodilutional therapy
for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes. Critical Care
Clinics, 1996; 12: 697-708
|